Please use this identifier to cite or link to this item: https://repositorio.ufrn.br/jspui/handle/123456789/25418
Title: Quality of life and adverse effects of olanzapine versus risperidone therapy in patients with schizophrenia
Authors: Araújo, Aurigena Antunes de
Chaves, Katarina Melo
Serrano-Blanco, Antoni
Ribeiro, Susana Barbosa
Soares, Luiz Alberto Lira
Guerra, Gerlane Coelho Bernardo
Alves, Maria do Socorro Costa Feitosa
Araújo Júnior, Raimundo Fernandes de
Rachetti, Vanessa de Paula Soares
Filgueira Júnior, Antônio
Keywords: Schizophrenia;Atypical antipsychotic;Quality of life
Issue Date: 18-Jul-2012
Publisher: Springer
Citation: ARAÚJO, Aurigena Antunes de et al. Quality of life and adverse effects of olanzapine versus risperidone therapy in patients with schizophrenia. Psychiatric Quarterly, v. 84, p. 125-135, 2012. Disponível em: <https://link.springer.com/article/10.1007%2Fs11126-012-9233-3>. Acesso em: 15 mar. 2018.
Portuguese Abstract: This cross-sectional study aimed to compare the effects of treatment with an atypical antipsychotic drug (olanzapine or risperidone) on quality of life (QoL) and to document adverse effects in 115 patients diagnosed with schizophrenia who attended the ambulatory service of Hospital Dr. João Machado, Natal, Rio Grande do Norte, Brazil. Socioeconomic, sociodemographic, and clinical variables were compared. The QoL Scale validated for Brazil (QLS-BR) was used to evaluate QoL, and adverse effects were assessed using the Udvalg for Kliniske Undersøgelser Side Effect Rating Scale. Data were analyzed using the χ2 test and Student’s t test, with a significance level of 5 %. Patients in both drug groups showed severe impairment in the occupational domain of the QLS-BR. Global QLS-BR scores indicated impairment among risperidone users and severe impairment among olanzapine users. The most significant side effects were associated with risperidone, including asthenia/lassitude/fatigue, somnolence/sedation, paresthesia, change in visual accommodation, increased salivation, diarrhea, orthostatic posture, palpitations/tachycardia, erythema, photosensitivity, weight loss, galactorrhea, decreased sexual desire, erectile/orgasmic dysfunction, vaginal dryness, headache, and physical dependence. QoL was impaired in patients using olanzapine and in those using risperidone. Risperidone use was associated with psychic, neurological, and autonomous adverse effects and other side effects.
URI: https://repositorio.ufrn.br/jspui/handle/123456789/25418
ISSN: 1573-6709
Appears in Collections:CB - DBF - Artigos publicados em periódicos

Files in This Item:
File Description SizeFormat 
Quality of Life and Adverse Effects of Olanzapine_2013.pdf195,05 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.